HRTX
HERON THERAPEUTICS, INC. /DE/
NASDAQ · Healthcare · Biotechnology · US
$0.31
−1.90%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.03
- Revenue estimate
- $37.5M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.03
- EPS estimate
- -$0.01
- Revenue actual
- $37.7M
- Revenue estimate
- $42.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -191.9%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.01 | -$0.03 | Miss -500.00% | $37.7M |
| May 11, 2026 | -$0.03 | -$0.04 | Miss -33.33% | $34.7M |
| Feb 26, 2026 | -$0.03 | -$0.02 | Beat 40.93% | $40.6M |
| Nov 4, 2025 | -$0.01 | -$0.05 | Miss -275.09% | $38.2M |
| Aug 8, 2025 | -$0.01 | -$0.02 | Miss -100.00% | $37.2M |
| Feb 27, 2025 | -$0.03 | $0.02 | Beat 166.67% | $40.8M |
| Mar 12, 2024 | -$0.15 | -$0.07 | Beat 53.33% | $34.2M |
| Nov 14, 2023 | -$0.31 | -$0.17 | Beat 45.16% | $31.4M |
| Aug 14, 2023 | -$0.23 | -$0.35 | Miss -52.17% | $31.8M |
| May 11, 2023 | -$0.17 | -$0.27 | Miss -58.82% | $29.6M |
| Mar 23, 2023 | -$0.25 | -$0.17 | Beat 32.00% | $30.0M |
| Feb 28, 2022 | -$0.59 | -$0.54 | Beat 8.47% | $20.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026